Literature DB >> 12445518

Systemic lupus erythematosus and related autoimmune diseases are antigen-driven, epigenetic diseases.

Wesley H Brooks1.   

Abstract

Autoimmune diseases result when cellular stresses (ex UV, cell cycle, hormones, viruses, and/or drugs) induce altered expression of polyamines, leading to chromatin disruption, interference with chromatin methylation, exposure of sequestered genes, and interference with tissue-specific processes. Exposure of previously sequestered Alu and LINE-1 sequences can lead to reverse transcription of Alu-RNA (and other transcripts) by the LINE-1 reverse transcriptase, yielding autoantigenic, hypomethylated DNA fragments. Release from the cell of the hypomethylated DNA fragments, along with polyamine-associated nucleoprotein complexes formed with the fragments, would elicit the autoimmune response. Loss of gene control due to hypomethylation and chromatin disruption by polyamines or other factors can include loss of dosage compensation from the inactive X chromosome for spermine synthase and spermidine/spermine N(1)-acetyltransferase at Xp22.1. This leads to ongoing altered polyamine levels. Thus, autoimmune diseases result from epigenetic changes that lead to autoantigen generation. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445518     DOI: 10.1016/s0306-9877(02)00322-5

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  A commentary on types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls.

Authors:  Wesley Brooks
Journal:  J Hum Genet       Date:  2014-02-06       Impact factor: 3.172

Review 2.  X chromosome inactivation and autoimmunity.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 3.  Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.

Authors:  Petar S Lenert
Journal:  Arthritis Res Ther       Date:  2006-01-10       Impact factor: 5.156

4.  Viral Impact in Autoimmune Diseases: Expanding the "X Chromosome-Nucleolus Nexus" Hypothesis.

Authors:  Wesley H Brooks
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

5.  Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus.

Authors:  Wesley H Brooks; Yves Renaudineau
Journal:  Front Genet       Date:  2015-02-16       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.